High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$9K
$9,618
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KPTI
S
Karyopharm Therapeutics Inc.
Abate Kristin
• Officer • Chief Accounting Officer
Discretionary Sell
2026-03-02
$5,260
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • Chief Accounting Officer
Discretionary Sell
|
2026-03-02 | $5,260 | S | Form 4 |
|
KPTI
S
Karyopharm Therapeutics Inc.
Abate Kristin
• Officer • Chief Accounting Officer
Discretionary Sell
2026-01-28
$352
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • Chief Accounting Officer
Discretionary Sell
|
2026-01-28 | $352 | S | Form 4 |
|
KPTI
S
Karyopharm Therapeutics Inc.
Abate Kristin
• Officer • Chief Accounting Officer
Discretionary Sell
2026-01-21
$1,579
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • Chief Accounting Officer
Discretionary Sell
|
2026-01-21 | $1,579 | S | Form 4 |
|
KPTI
S
Karyopharm Therapeutics Inc.
Abate Kristin
• Officer • Chief Accounting Officer
Discretionary Sell
2025-10-01
$2,279
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • Chief Accounting Officer
Discretionary Sell
|
2025-10-01 | $2,279 | S | Form 4 |
|
KPTI
S
Karyopharm Therapeutics Inc.
Abate Kristin
• Officer • Chief Accounting Officer
Discretionary Sell
2025-09-15
$148
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • Chief Accounting Officer
Discretionary Sell
|
2025-09-15 | $148 | S | Form 4 |